Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

EPOPROSTENOL vs EQUINE THYMOCYTE IMMUNE GLOBULIN: Safety Overview

Metric EPOPROSTENOL EQUINE THYMOCYTE IMMUNE GLOBULIN
Total FAERS Reports 13,322 763
Deaths Reported 2,713 155
Death Rate 20.4% 20.3%
Hospitalizations 8,838 204
Average Patient Age 49.9 yrs 41.0 yrs
% Female Patients 78.1% 62.2%
FDA Approval Date Apr 23, 2008 N/A
Manufacturer Mylan Institutional LLC Uriel Pharmacy Inc.
Route INTRAVENOUS ORAL
Marketing Status Discontinued N/A